Skip to main content

Table 2 Univariate analysis: local control survival for OLTs from CRC and early stage NSCLC

From: A matched-pair analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer versus early stage non-small cell lung cancer

Factors CRC NSCLC
p 95% CI p 95% CI
Age 0.31 0.10–1.15 0.85 0.83–1.17
Location 0.34 0.42–1.35 0.34 0.09–2.3
Tumor size 0.72 0.07–6.39 0.95 0.05–23.41
RT dose (BED10) 0.02 1.35–53.89 0.15 0.76–5.87
Baseline SUVmax 0.38 0.42–1.38 0.47 0.82–1.53
KRAS-mutation status 0.23 0.00–16.83